Pharming Group N.V. Files Form 6-K
Ticker: PHAR · Form: 6-K · Filed: Mar 4, 2025 · CIK: 1828316
| Field | Detail |
|---|---|
| Company | Pharming Group N.V. (PHAR) |
| Form Type | 6-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, press-release
TL;DR
Pharming Group N.V. dropped a 6-K filing on 3/4/25, likely with news in the attached press release.
AI Summary
Pharming Group N.V. filed a Form 6-K on March 4, 2025, to furnish a press release dated the same day. The filing does not contain specific financial figures or operational updates in the provided text, but indicates the submission of Exhibit 99.1, which is the press release itself.
Why It Matters
This filing serves as a notification to the SEC about the release of important company information, typically a press release, which could contain material updates for investors.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of a press release and does not contain inherently risky information.
Key Players & Entities
- Pharming Group N.V. (company) — Registrant
- March 4, 2025 (date) — Filing and Press Release Date
- 001-39822 (other) — SEC File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to furnish a press release dated March 4, 2025, as Exhibit 99.1, to the U.S. Securities and Exchange Commission.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is March 4, 2025.
What is the SEC file number for Pharming Group N.V.?
The SEC file number for Pharming Group N.V. is 001-39822.
What is the address of Pharming Group N.V.'s principal executive offices?
The address of Pharming Group N.V.'s principal executive offices is Darwinweg 24, 2333 CR Leiden, The Netherlands.
What exhibit is furnished with this Form 6-K?
Exhibit 99.1, a press release of Pharming Group N.V. dated March 4, 2025, is furnished with this Form 6-K.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 4, 2025 regarding Pharming Group N.V. (PHAR).